Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Solodyn
Differential diagnosis for cervical spondylotic myelopathy: literature review.
Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis.
Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab For Relapsing-Remitting Multiple Sclerosis.
Building a better sphingosine kinase-1 inhibitor.
Quantitative assessment of multiple sclerosis using inertial sensors and the TUG test.
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
Raltegravir (Isentress) pilot study in relapsing multiple sclerosis (INSPIRE)
Noninvasive molecular imaging of neuroinflammation.
New Drug Review 2010: Ustekinumab (Stelara, Centocor Ortho Biotech)
Investigational Laquinimod Demonstrates Its Potential as a New Oral Treatment For RRMS
A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta.
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
Molecular targets of FTY720 (fingolimod).
The impact of environmental infections (parasites) on MS activity.
The mammalian Na+/H+ exchanger gene family--initial structure/function studies.
Motor programme activating therapy influences adaptive brain functions in multiple sclerosis: clinical and MRI study.
Management of multiple sclerosis: An overview.
Epidermal pigmentation in the human lineage is an adaptation to ultraviolet radiation.
Investigating Axonal Damage in Multiple Sclerosis by Diffusion Tensor Spectroscopy.
Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.
Submembranous cytoskeletons stabilize nodes of Ranvier.
Direct angiotensin AT2-receptor stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice.
Vitamin D: a natural inhibitor of multiple sclerosis.
Structure and Activity of the Acid Sensing Ion Channels.
Pages
« first
‹ previous
…
160
161
162
163
164
165
166
167
168
…
next ›
last »